PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
The past year has been marked by near-constant upheaval, with new, revised or abandoned directives emerging from the Oval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback